Cabaletta Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.01

+0.10 (+3.44%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 3 19%

Sell 0 0%

Price Target

Analyst Price Target +1,221.9% upside

Low Target $29.42

Average Target $39.79

High Target $58.63

Current Price $3.01

Current
$3.01

Target
$39.79

$29.42 $39.79 avg $58.63

Scenario Analysis

Bear Case

$29.42

877.4%

Low target

Base Case

$39.79

+1,221.9%

Avg target

Bull Case

$58.63

+1,847.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.23

-28.8% from high

52-Week Low

$1.35

+123.0% from low

Target vs 52W High

$39.79

+840.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-0.5%
AMGN Amgen Inc	Hold	43	49%	$190.87	-55.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+152.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.1%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-47.2%
BIIB Biogen Inc	Buy	43	67%	$91.45	-57.0%